[ad_1] Glenmark Pharmaceuticals Inc., USA (Glenmark) and Glenmark Pharmaceuticals Limited have reached an agreement with Pfizer Inc., PF Prism CV and PF Prism IMB BV (Pfizer) for their generic version of Axitinib tablets, 1 mg and 5 mg. Inlyta®1 tablets, 1 mg and 5 mg. Glenmark announced on November 30, 2020 that it has received … Read more
[ad_1] Glenmark Pharmaceuticals Inc., USA (Glenmark) and Glenmark Pharmaceuticals Limited have reached an agreement with Pfizer Inc., PF Prism CV and PF Prism IMB BV (Pfizer) for their generic version of Axitinib tablets, 1 mg and 5 mg. Inlyta®1 tablets, 1 mg and 5 mg. Glenmark announced on November 30, 2020 that it has received … Read more
[ad_1] Glenmark Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration (US FDA) for Sodium Phenylbutyrate Tablets USP, 500 mg, Generic Version Buphenyl Tablets, 500 mg, Horizon Therapeutics, LLC. According to the filings, Glenmark’s Sodium Phenylbutyrate Tablets USP, 500 mg, is distributed in the USA by Glenmark Pharmaceuticals Inc., USA. … Read more